Pediatrics, Critical Care Medicine

• 

  People

  • Administrative Positions

    • Allareddy, Veerajalandhar, Chief of the Section of Pediatric Cardiac Care
    • Rotta, Alexandre Tellechea, Chief, Division of Pediatric Critical Care Medicine
    • Turner, David Ashley, Section Chief, Pediatric Intensive Care

  • Primary Appointments

    • Adams, David Frederick, Consulting Associate in the Department of Pediatrics
    • Allareddy, Veerajalandhar, Professor of Pediatrics
    • Hornik, Christoph Paul Vincent, Associate Professor of Pediatrics
    • Jackson, Kimberly, Assistant Professor of Pediatrics
    • Kamath, Sameer Shantaram, Associate Professor of Pediatrics
    • Kumar, Karan Ravindra, Assistant Professor of Pediatrics
    • Mallory, Palen Powelson, Assistant Professor of Pediatrics
    • Ozment, Caroline Pinson, Assistant Professor of Pediatrics
    • Ray, Candice Marlow, Adjunct Associate in the Department of Pediatrics
    • Rehder, Kyle Jason, Associate Professor of Pediatrics
    • Rotta, Alexandre Tellechea, Professor of Pediatrics
    • Sherwin, Jennifer, Assistant Professor of Pediatrics
    • Sullivan, John Stephen, Adjunct Associate Professor in the Department of Pediatrics
    • Turi, Jennifer Lilly, Associate Professor of Pediatrics
    • Turner, David Ashley, Consulting Professor in the Department of Pediatrics
    • Vesel, Travis Prentiss, Assistant Professor of Pediatrics
    • Williams, David Jeffrey, Assistant Consulting Professor in the Department of Pediatrics
    • Zimmerman, Kanecia Obie, Associate Professor of Pediatrics

  • Secondary Appointments

    • Greeley, William J., Adjunct Professor in the Department of Pediatrics
• 

  Administers Grant

  • 7 day study of the safety, efficacy and the pharmacokinetic and pharmacodyamic properties of oral rivaroxaban in children from birth to less than 6 months with catheter-related aterial or venous thrombosis
  • A Phase 1b, Multicenter, double blind randomized controlled dose escalating trial of fentanyl vs. fentanyl + dexmedetomidine as the initial regimen for maintenance of sedation in mechanically-ventilated, critically ill children
  • A Phase 2/3 Randomized, Openn-Label, Multi-center Study to Determine the Safety and Efficacy of Solithromycin in Adolescents (12 to17 years of age, inclusive) and Children (>- 2 months to < 12 years of age) with Suspected or Confirmed Community
  • A Phase 3, Multicenter, open-label, randomized, comparator controlled trial of the safety and efficacy of dalbavancin versus active comparator in pediatric subjects with acute bacterial skin and skin structure infections.
  • A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A; IRC-005
  • ARDS in Children and ECMO initiation strategies impact on Neuro-Development (ASCEND)
  • CAZ-AVI (Ceftazidime-Avibactam)
  • Clinical Pharmacokinetics and Safety Trials in Down Syndrome
  • HALF-PINT: Heart and Lung Failure - Pediatric INsulin Titration trial - CCC
  • Mechanisms of Intracellular Iron Accumulation in Cystic Fibrosis
  • Oxycontin Drug Utilization in Children
  • POP V (Duke 08) TO 49
  • PROSpect - Prone and Oscillation Pediatric Clinical Trial
  • Pediatric Critical Care Research Landscape - A National Expert Conference
  • Pharmacokinetics and Safety Profile of Digoxin in Infants with Single Ventricle Congenital Heart Disease
  • Pharmacokinetics and Safety of Anesthetics and Analgesics in Children
  • Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
  • Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
  • Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
  • Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care
  • Pharmacokinetics of a Single-Dose of Dalbavancin in Preterm Neonates to Infants Ages 3 Months with Suspected or Confirmed Bacterial Infection
  • Pharmacokinetics of ant-epileptic Drugs in Obese Children (HHSN-275201000003I)
  • Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POPS)
  • Real World Data to Support Pediatric Drug Labeling
  • SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
  • Understanding COVID-19 among critically ill children in the Pediatric Acute Lung Injury and Sepsis Investigator's (PALISI) Network

Add data to my Website